Cellid Co., Ltd. Logo

Cellid Co., Ltd.

Develops immunotherapeutic vaccines for cancer and infectious diseases.

299660 | KO

Overview

Corporate Details

ISIN(s):
KR7299660001
LEI:
Country:
South Korea
Address:
서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시

Description

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-09-18 00:00
소송등의제기ㆍ신청(일정금액이상의청구)
Korean HTML 8.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1015.8 KB
2025-08-12 00:00
소송등의판결ㆍ결정(일정금액이상의청구)
Korean HTML 7.0 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 28.4 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 25.5 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 27.6 KB
2025-06-30 00:00
[기재정정]주식매수선택권부여에관한신고
Korean HTML 26.2 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB
2025-06-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 25.1 KB

Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cellid Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.